Search alternatives:
algorithm python » algorithms within (Expand Search), algorithm both (Expand Search)
within function » fibrin function (Expand Search), protein function (Expand Search), catenin function (Expand Search)
python function » protein function (Expand Search)
algorithm npc » algorithm etc (Expand Search), algorithm pca (Expand Search), algorithm _ (Expand Search)
npc function » spc function (Expand Search), gpcr function (Expand Search), fc function (Expand Search)
algorithm python » algorithms within (Expand Search), algorithm both (Expand Search)
within function » fibrin function (Expand Search), protein function (Expand Search), catenin function (Expand Search)
python function » protein function (Expand Search)
algorithm npc » algorithm etc (Expand Search), algorithm pca (Expand Search), algorithm _ (Expand Search)
npc function » spc function (Expand Search), gpcr function (Expand Search), fc function (Expand Search)
-
2181
Image_1_A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.TIF
Published 2021“…In the MRSB high-risk group, the hazard curve exhibited an initial wide, high peak within 10 months after treatment, whereas some gentle peaks around 2 years were noted. …”
-
2182
Image_2_A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.TIF
Published 2021“…In the MRSB high-risk group, the hazard curve exhibited an initial wide, high peak within 10 months after treatment, whereas some gentle peaks around 2 years were noted. …”
-
2183
Image_3_A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.TIF
Published 2021“…In the MRSB high-risk group, the hazard curve exhibited an initial wide, high peak within 10 months after treatment, whereas some gentle peaks around 2 years were noted. …”
-
2184
Data_Sheet_1_A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.CSV
Published 2021“…In the MRSB high-risk group, the hazard curve exhibited an initial wide, high peak within 10 months after treatment, whereas some gentle peaks around 2 years were noted. …”
-
2185
Table_1_A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.XLSX
Published 2021“…In the MRSB high-risk group, the hazard curve exhibited an initial wide, high peak within 10 months after treatment, whereas some gentle peaks around 2 years were noted. …”
-
2186
Image_4_A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.TIF
Published 2021“…In the MRSB high-risk group, the hazard curve exhibited an initial wide, high peak within 10 months after treatment, whereas some gentle peaks around 2 years were noted. …”
-
2187
Data_Sheet_2_A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.CSV
Published 2021“…In the MRSB high-risk group, the hazard curve exhibited an initial wide, high peak within 10 months after treatment, whereas some gentle peaks around 2 years were noted. …”
-
2188
DataSheet1_Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models.docx
Published 2024“…Moreover, leveraging the GSE102484 dataset, we conducted differential gene expression analysis to identify MRGs related to metastasis, subsequently developing metastasis models via 10 distinct machine-learning algorithms and then selecting the best-performing model. …”
-
2189
Table1_Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models.xlsx
Published 2024“…Moreover, leveraging the GSE102484 dataset, we conducted differential gene expression analysis to identify MRGs related to metastasis, subsequently developing metastasis models via 10 distinct machine-learning algorithms and then selecting the best-performing model. …”
-
2190
Table2_YinChen WuLing powder attenuates non-alcoholic steatohepatitis through the inhibition of the SHP2/PI3K/NLRP3 pathway.xlsx
Published 2024“…Through analytic integration with multiple algorithms, PTPN11 (also known as SHP2) emerged as a core target of YCWLP in mitigating NASH. …”
-
2191
Table1_YinChen WuLing powder attenuates non-alcoholic steatohepatitis through the inhibition of the SHP2/PI3K/NLRP3 pathway.pdf
Published 2024“…Through analytic integration with multiple algorithms, PTPN11 (also known as SHP2) emerged as a core target of YCWLP in mitigating NASH. …”